Document is current
Any future updates will be listed below
-
Authors
Alborelli, Ilaria http://orcid.org/0000-0001-7849-3958
Generali, Daniele
Jermann, Philip
Cappelletti, Maria Rosa
Ferrero, Giuseppina
Scaggiante, Bruna
Bortul, Marina
Zanconati, Fabrizio
Nicolet, Stefan
Haegele, Jasmin
Bubendorf, Lukas
Aceto, Nicola
Scaltriti, Maurizio http://orcid.org/0000-0002-5522-1447
Mucci, Giuseppe
Quagliata, Luca
Novelli, Giuseppe
- License Information
-
More Information
Article History
Received: 27 March 2019
Revised: 14 June 2019
Accepted: 18 June 2019
First Online: 11 July 2019
Conflict of interest
: P.J., L.Q., N.A. and M.S. were at the time of this project establishment part of the Scientific Advisory Board of the Bioscience Institute. I.A. and P.J. report grants from BMS and non-financial support from Thermo Fisher Scientific. G.M. is the Founder and CEO of the Bioscience Institute SpA. L.Q. no longer serves on the Bioscience Institute Scientific Board and currently is an Employer of Thermo Fisher Scientific. He has joined Thermo Fisher Scientific when this project was already accomplished and only manuscript had to be written. L.B. reports grants and personal fees from Roche, grants and personal fees from MSD, personal fees from BMS, personal fees from Astra Zeneca. N.A. is a paid consultant for pharmaceutical and insurance companies with an interest in liquid biopsy, and he is listed as inventor in several patent applications related to cancer detection and treatment. M.S. has received research funds from Puma Biotechnology, Daiichi-Sankio, Immunomedics, Targimmune and Menarini Ricerche, and is a cofounder of Medendi Medical Travel. The remaining authors declare that they have no conflict of interest.
